Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza A virus H1N1 vaccine intranasal - BioDiem/Serum Institute of India

Drug Profile

Influenza A virus H1N1 vaccine intranasal - BioDiem/Serum Institute of India

Alternative Names: LAIV influenza A vaccine H1N1 - SII; Live-attenuated influenza virus vaccine H1N1; Nasovac; Pandemic influenza A H1N1 - intranasal

Latest Information Update: 04 Mar 2014

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Institute of Experimental Medicine of the Russian Academy of Medical Sciences
  • Developer Serum Institute of India
  • Class Influenza A virus H1N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza A virus H1N1 subtype

Most Recent Events

  • 31 Jul 2010 Launched for Influenza-A virus H1N1 subtype in India (Intranasal)
  • 10 Jul 2010 The Serum Institute of India completes a phase II/III trial in Influenza-A virus H1N1 (prevention, in paediatric, adult and elderly volunteers) in India
  • 10 Jul 2010 The Serum Institute of India completes a phase I trial in Influenza-A virus H1N1 (prevention, in volunteers) in India

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top